Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Higher 30-day mortality, poor outcomes linked to early surgery in older adults with TBI
In older adults with traumatic brain injury and acute subdural hematoma, early neurosurgical intervention resulted in the highest 30-day mortality rates, while delayed surgery yielded better outcomes.
Systolic BP should not inform decision to withhold, delay endovascular thrombectomy
High or low systolic blood pressure on hospital admission did not negate the effects of endovascular thrombectomy in patients with ischemic stroke, although higher levels were associated with worse functional outcomes.
Log in or Sign up for Free to view tailored content for your specialty!
When evaluating financial advisors, understand how they make money
Today’s economic environment and market volatility have caused many DIY investors to reconsider working with professional financial advisors. Those who work with advisors also may be evaluating their advisor and investigating alternatives.
Umbrella review finds ‘inconclusive evidence’ supporting cognitive benefits of exercise
After re-examining more than 20 meta-analyses of randomized controlled trials, researchers said they found “inconclusive evidence” supporting a positive link between regular physical exercise and cognition in healthy participants.
FDA places partial clinical hold on initiation of new patients in evobrutinib study
Merck KGaA announced the FDA has paused the initiation of new patients on evobrutinib for relapsing-remitting MS, as well as those with less than 70 days exposure to the treatment in the United States.
FDA grants fast track designation for novel Duchenne muscular dystrophy gene therapy
Regenxbio Inc. announced that the FDA has granted fast track designation for RGX-202, a one-time gene therapy for treatment of Duchenne muscular dystrophy.
FDA grants 510(k) clearances to triage, notification findings on chest, head imaging
The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.
More than 40% of patients with long COVID report mild to severe sleep disturbances
More than 40% of patients with long COVID reported having mild to severe sleep disturbances, with Black individuals and those hospitalized for COVID-19 at greater risk for worsened sleep, a recent study found.
Neurostimulation device reduces seizure frequency in adults with drug-refractory epilepsy
In adults with drug-refractory focal epilepsy, treatment with an implanted neurostimulation device was safe and associated with significant reduction in seizure frequency, according to a study published in JAMA Neurology.
Phase 1/2a trial commenced for Alzheimer’s dementia immunotherapy
Alzamend Neuro Inc. announced initiation of a phase 1/2a clinical trial for its proprietary immunotherapy vaccineALZN002 to treat mild to moderate dementia associated with Alzheimer’s disease.
-
Headline News
‘It’s going to be ubiquitous’: Weight loss drugs may aid rheumatic disease treatment
September 30, 20242 min read -
Headline News
People with an eating disorder, electrolyte abnormality faced increased risk for death
September 30, 20242 min read -
Headline News
Balance between excitement, inhibition key to treat hypoactive sexual desire disorder
October 01, 20244 min read
-
Headline News
‘It’s going to be ubiquitous’: Weight loss drugs may aid rheumatic disease treatment
September 30, 20242 min read -
Headline News
People with an eating disorder, electrolyte abnormality faced increased risk for death
September 30, 20242 min read -
Headline News
Balance between excitement, inhibition key to treat hypoactive sexual desire disorder
October 01, 20244 min read